Peripherally restricted cannabinoid type 1 receptor (CB1R) antagonist, AM6545, potentiates stress-induced hypothalamic-pituitary-adrenal axis activation via a non-CB1R mechanism

Endocrine. 2021 Apr;72(1):297-300. doi: 10.1007/s12020-020-02549-1. Epub 2020 Nov 20.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cannabinoid Receptor Antagonists / pharmacology*
  • Female
  • Hypothalamo-Hypophyseal System*
  • Male
  • Mice
  • Mice, Inbred ICR
  • Morpholines
  • Pituitary-Adrenal System*
  • Pyrazoles
  • Receptor, Cannabinoid, CB1

Substances

  • AM6545
  • Cannabinoid Receptor Antagonists
  • Morpholines
  • Pyrazoles
  • Receptor, Cannabinoid, CB1